David Frankel, MD
Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1669458287
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $176,300 of the $218,197 with a category attached, or 80.8%. Medtronic accounts for 76.4% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $56,791, 3.6 times the $15,698 reported in 2019. Among clinical cardiac electrophysiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $779.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$167K
- Boston Scientific$16K
- Medical Device Business Services, Inc.$9K
- Abbott$8K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$6K
- Biosense Webster, Inc.$5K
- plus $7K from 15 others
Across 105 payments — averaging $4794.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$234K
- Biosense Webster, Inc.$195K
- Abbott$71K
- Medical Device Business Services, Inc.$4K
What the payments were for
- Consulting fees$22,30710%
- Speaking & faculty fees$176,30081%
- Travel & lodging$12,1536%
- Food & beverage$7,4373%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 150 | $166,681 |
| Boston Scientific | 36 | $15,636 |
| Medical Device Business Services, Inc. | 8 | $8,957 |
| Abbott | 27 | $8,296 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $6,015 |
| Biosense Webster, Inc. | 15 | $5,354 |
| Stryker | 7 | $3,924 |
| AstraZeneca | 1 | $2,400 |
| Lundbeck LLC | 7 | $192 |
| Biotronik Inc. | 1 | $185 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| Philips North America LLC | 3 | $91 |
| Inari Medical, Inc. | 1 | $71 |
| Cardiva Medical, Inc. | 2 | $42 |
| Irhythm Technologies, Inc. | 2 | $42 |
| Avanir Pharmaceuticals, Inc. | 2 | $36 |
| Pfizer | 2 | $35 |
| Johnson & Johnson | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$16,057
- Farapulse$9,574
- LifeVest$6,000
- GALLANT$5,000
- REPROCESSED EP CATHETERS$3,150
- EMBLEM$3,150
- Carto 3 System$2,400
- ANDEXXA$2,400
- CLINICAL TRIAL PRODUCT$1,406
- AVEIR$1,378
- S-ICD System Magnet$875
- ENSITE PRECISION$825
- N/A$700
- STERRAD$419
- ENSITE$151
- Ensite Cardiac Mapping System$145
- TYRX$140
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$137
- WATCHMAN Access System$134
- VenaSeal$121
How this compares
$218,197 in reported general payments places this provider in the 90th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $41,830 |
| XareltoRivaroxaban | 12 | $10,992 |
| Flecainide Acetate | 18 | $908 |
| Metoprolol Succinate | 65 | $780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $41,83042 claims |
| Johnson & JohnsonXarelto | $34 | $10,99212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Philadelphia
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pasquale SantangeliPhiladelphia$581K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
- Timothy MarkmanPhiladelphia$402K
- David CallansPhiladelphia$350K
- Robert SchallerPhiladelphia$333K
- Matthew HymanPhiladelphia$294K
- Rajat DeoPhiladelphia$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.